These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7051236)

  • 1. Trimethoprim alone for treatment of urinary tract infection.
    Neu HC
    Rev Infect Dis; 1982; 4(2):366-71. PubMed ID: 7051236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimethoprim alone in the treatment of urinary tract infections: eight years of experience in Finland.
    Kasanen A; Sundquist H
    Rev Infect Dis; 1982; 4(2):358-65. PubMed ID: 7051235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimethoprim-sulfamethoxazole and trimethoprim alone in the prophylaxis of childhood urinary tract infection.
    Smellie JM; Grüneberg RN; Normand IC; Bantock HM
    Rev Infect Dis; 1982; 4(2):461-6. PubMed ID: 6981164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis.
    Fox BC; Sollinger HW; Belzer FO; Maki DG
    Am J Med; 1990 Sep; 89(3):255-74. PubMed ID: 2118307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind comparison of sulphonamide-trimethoprim combinations in acute uncomplicated urinary tract infections.
    Skjerven O; Bergan T
    Infection; 1979; 7 Suppl 4():S398-400. PubMed ID: 389813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy and safety of nalidixic acid versus trimethoprim/sulfamethoxazole in treatment of acute urinary tract infections in college-age women.
    Iravani A; Richard GA; Baer H; Fennell R
    Antimicrob Agents Chemother; 1981 Apr; 19(4):598-604. PubMed ID: 6972732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary prophylaxis with trimethoprim and trimethoprim-sulfamethoxazole: efficacy, influence on the natural history of recurrent bacteriuria, and cost control.
    Stamm WE; Counts GW; McKevitt M; Turck M; Holmes KK
    Rev Infect Dis; 1982; 4(2):450-5. PubMed ID: 6981163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled study of trimethoprim-sulfamethoxazole prophylaxis of urinary tract infection in renal transplant recipients.
    Tolkoff-Rubin NE; Cosimi AB; Russell PS; Rubin RH
    Rev Infect Dis; 1982; 4(2):614-8. PubMed ID: 7051249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of trimethoprim and trimethoprim-sulfamethoxazole on development of drug-resistant vaginal and fecal floras.
    Pancoast SJ; Hyams DM; Neu HC
    Antimicrob Agents Chemother; 1980 Feb; 17(2):263-8. PubMed ID: 7387147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordinated multicenter study of norfloxacin versus trimethoprim-sulfamethoxazole treatment of symptomatic urinary tract infections. The Urinary Tract Infection Study Group.
    J Infect Dis; 1987 Feb; 155(2):170-7. PubMed ID: 2879872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute cystitis: a prospective study of laboratory tests and duration of therapy.
    Schultz HJ; McCaffrey LA; Keys TF; Nobrega FT
    Mayo Clin Proc; 1984 Jun; 59(6):391-7. PubMed ID: 6427533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experiences with trimethoprim-sulfamethoxazole in ambulatory urologic practice].
    Thomas J
    Fortschr Med; 1979 May; 97(17):831-4. PubMed ID: 437645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethoprim-resistant Enterobacteriaceae in urinary tract infection.
    Wong CK; Harding GK; Ronald AR; Hoban S
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):54-8. PubMed ID: 1093652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Choice of treatment in recurrent urinary infections in childhood].
    Sánchez Bayle M; Barrio Pérez ML; Estepa Soto MR; López Verde L
    An Esp Pediatr; 1984 Jan; 20(1):28-32. PubMed ID: 6608301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The bioavailability and clinical efficay of drylin, a new drug combination of TMP/SMZ].
    Rilling GJ
    Fortschr Med; 1977 Sep; 95(25):2167-70. PubMed ID: 410716
    [No Abstract]   [Full Text] [Related]  

  • 16. Rifaprim in urinary tract infection: a comparison with co-trimoxazole.
    Kosmidis J; Giamarellou H; Papadakis M; Eliades E; Daikos GK
    J Antimicrob Chemother; 1983 Mar; 11(3):239-44. PubMed ID: 6601648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic co-trimoxazole and trimethoprim in the management of urinary tract infection in children.
    Smellie JM; Grüneberg RN; Bantock HM; Prescod N
    Pediatr Nephrol; 1988 Jan; 2(1):12-7. PubMed ID: 3152984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of experimentally induced enterotoxigenic Escherichia coli diarrhea with trimethoprim, trimethoprim-sulfamethoxazole, or placebo.
    Black RE; Levine MM; Clements ML; Cisneros L; Daya V
    Rev Infect Dis; 1982; 4(2):540-5. PubMed ID: 7051247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of trimethoprim-sulfamethoxazole in the treatment of chest infections.
    Hughes DT; Russell NJ
    Rev Infect Dis; 1982; 4(2):528-32. PubMed ID: 7051245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal groups and the spread of resistance to trimethoprim-sulfamethoxazole in uropathogenic Escherichia coli.
    France AM; Kugeler KM; Freeman A; Zalewski CA; Blahna M; Zhang L; Marrs CF; Foxman B
    Clin Infect Dis; 2005 Apr; 40(8):1101-7. PubMed ID: 15791508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.